KA
Keene & Associates’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.52M | Sell |
95,073
-16,929
| -15% | -$449K | 2.03% | 25 |
|
|
2024
Q3 | $3.24M | Buy |
112,002
+315
| +0.3% | +$9.12K | 2.46% | 21 |
|
|
2024
Q2 | $3.13M | Sell |
111,687
-534
| -0.5% | -$14.9K | 2.55% | 23 |
|
|
2024
Q1 | $3.11M | Buy |
112,221
+48,106
| +75% | +$1.33M | 2.33% | 28 |
|
|
2023
Q4 | $1.85M | Sell |
64,115
-3,848
| -6% | -$111K | 1.53% | 29 |
|
|
2023
Q3 | $2.25M | Buy |
67,963
+2,571
| +4% | +$85.3K | 1.81% | 29 |
|
|
2023
Q2 | $2.4M | Buy |
65,392
+1,900
| +3% | +$69.7K | 1.86% | 31 |
|
|
2023
Q1 | $2.59M | Sell |
63,492
-201
| -0.3% | -$8.2K | 2.01% | 31 |
|
|
2022
Q4 | $3.26M | Buy |
63,693
+1,613
| +3% | +$82.7K | 2.91% | 12 |
|
|
2022
Q3 | $2.72M | Sell |
62,080
-2,850
| -4% | -$125K | 2.5% | 18 |
|
|
2022
Q2 | $3.4M | Buy |
64,930
+125
| +0.2% | +$6.55K | 3.19% | 5 |
|
|
2022
Q1 | $3.36M | Sell |
64,805
-673
| -1% | -$34.8K | 2.74% | 17 |
|
|
2021
Q4 | $3.87M | Buy |
+65,478
| New | +$3.87M | 3.34% | 2 |
|